Market entry of YpsoMate autoinjector for Teribone™ in Japan
Teribone™ autoinjector

Market entry of YpsoMate autoinjector for Teribone™ in Japan

News – Ypsomed Delivery Systems

Burgdorf – Terumo Corporation (Terumo), a leading global manufacturer and distributor of medical devices, will fill its PLAJEX™ syringe with the drug Teribone™ and assemble it with the YpsoMate prefilled autoinjector from Ypsomed. Teribone™ is a Teriparatide for the treatment of osteoporosis. The drug was developed by Asahi Kasei Pharma (AKP) and will be launched in Japan.

Read more...

YpsoDose patch injector in use

User-friendliness of YpsoDose patch injector confirmed

Satisfied user study participants

News – Ypsomed Delivery Systems

YpsoDose is a patch injector for large volumes. When developing YpsoDose, we focus on user-friendliness as we do with all our injection systems. The latest user studies have confirmed how easy YpsoDose is to use. 

Read more...

Ypsomed's autoinjector YspoMate

Ypsomed's autoinjectors are in popular demand on the market

YpsoMate's platform approach is paying off

News – Ypsomed Delivery Systems

Several customers have recently launched their autoinjectors based on our YpsoMate platform product technology on the market. Customers value the fast product customisation as well as the individual design possibilities. End users appreciate its user-friendliness.

Read more...

Copaxone PEN from Teva

Teva launches Copaxone with the YpsoMate autoinjector from Ypsomed

News – Ypsomed Delivery Systems

Burgdorf – Teva Pharmaceutical Industries Ltd. (Teva), a global leader in generic medicines with innovative treatments in select areas, including CNS, pain and respiratory, has launched its drug product Copaxone® in the pre-filled autoinjector YpsoMate® from Ypsomed. Copaxone® is used for the treatment of patients with relapsing forms of multiple sclerosis (MS). The collaboration with Teva marks the
second commercial market entry of Ypsomed’s autoinjector YpsoMate®.

Read more...

First market entry of YpsoMate autoinjector from Ypsomed

News – Ypsomed Delivery Systems

Burgdorf – Terumo Corporation (Terumo), a leading global manufacturer and distributor of medical devices, will fill its PLAJEX syringe with the drug Hulio® and assemble it with the YpsoMate prefilled autoinjector from Ypsomed. Hulio® is a biosimilar to Humira® (adalimumab) developed by Fujifilm Kyowa Kirin Biologics Co., Ltd. and marketed in the European Union by Mylan N.V. The drug is used in the treatment of various chronic autoimmune diseases.

Read more...